Kircali, E. Et Al. 2020. Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent. BLOOD , vol.136, no.Supplement 1 , 13-14.

Kircali, E., Cengiz, G., Çolak, S., Gunduz, M., Ataca Atilla, P., Atilla, E., ... Özen, M.(2020). Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent. BLOOD , vol.136, no.Supplement 1, 13-14.

Kircali, Ekin Et Al. "Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent," BLOOD , vol.136, no.Supplement 1, 13-14, 2020

Kircali, Ekin Et Al. "Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent." BLOOD , vol.136, no.Supplement 1, pp.13-14, 2020

Kircali, E. Et Al. (2020) . "Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent." BLOOD , vol.136, no.Supplement 1, pp.13-14.

@article{article, author={Ekin Kircali Et Al. }, title={Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent}, journal={BLOOD}, year=2020, pages={13-14} }